ReviewNeuro-oncology advances2026

MEK inhibitors for neurofibromatosis type 1-associated central and peripheral nervous system tumors.

Chelsea Kotch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.